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Secondary structure is not typically observed for small peptides in solution. Several of the properties of a-helical peptides 
are known which lead to the stabilization of the structure. The utilization of all the known factors important for a-helical 
stabilization in the design of model a-helical peptides (MAP) is reported. The peptides are based on the repeating eleven 
amino acid sequence, Glu-LX-Leu-Glu-Lys-IXU-Leu-Glu-Lys-Leu-Lys (MAP,_,,). The CD spectra of these peptides 
give evidence for more a-helical content than has been reported for any short peptide (< 18 amino acids) to date. This 
a-helical tendency does not require the presence of lipid or reduced temperature. For instance, Sue-[TrpP]MAP, -3- amide 
(5), a seventeen amino acid peptide has lw and 80$% a-helical contents at 1.7 x 10m4 M and 1.7 x IO-” M, respectively. 
Sue-p$]MAP, _11 amide (3), merely ten amino acids in length, is 51% a-helical at 1.7 x 10e4 M in 0.1 M phosphate 
btier at room temperature. In the presence of lipid or trifluoroethanol, the a-helical content of these peptides is increased. 
This series of peptides demonstrates the complimentarity of various secondary structure design principles and the extent 
to which structure can be induced in small linear peptides. 
Amphipathic a-helix, Model peptide 
1. INTRODUCTION 
Many efforts have been directed at the design of 
model peptides that form stable a-helices in the 
presence of lipid [l-8] or alone in aqueous solu- 
tion [9]. Such peptides are valuable in under- 
standing the forces that govern secondary structure 
formation and the mode of interaction of lipid- 
binding peptides with membranes. Short peptides 
(< 18 amino aids) that have a high amount of cy- 
helical content (>80%) in aqueous solution at 
room temperature in the absence of lipid have not 
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yet been reported. Also, the minimum length of 
peptides having high a-helical tendency and lipid- 
binding affinity has not been established. A lower 
limit of as few as 13 residues has been suggested 
for the formation of a helical structure, based on 
work with ribonuclease A [l-13] at 0°C [lo]. 
Typically, small peptides that have been reported 
to date have high amounts of a-helical content 
only at reduced temperature or in the presence of 
lipid [l-8]. In the present studies, a model am- 
phipathic a-helical peptide (MAP) sequence was 
designed incorporating several means of a-helical 
stabilization and amphipathic analysis in order to 
produce a series of short, highly a-helical peptides 
that have a simple and regular sequence and also 
have the ability to bind lipid. 
The first criterion in the design of MAP was that 
amino acids had the highest probability of being 
found in an a-helical peptide and a low probability 
of &sheet or turn structures. Leu, Lys and Glu 
were chosen on this basis from their corresponding 
Pa, Pa and Pt values of Chou and Fastin [l 11. Se- 
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cond, the Lys residues were positioned on the 
lateral faces of the a-helix and the Glu residues op- 
posite the Leu residues (fig.2). This was done to 
provide the optimal charge distribution fur lipid 
interaction [3]. Such a regular distribution of func- 
tional groups might also promote aggregation. 
Third, the size of the lipophilic face of the am- 
phipathic a-helix probably has a great effect on the 
nature of the peptide-lipid interaction, thus, the 
lipophilic region was modelled after a well 
characterized lipid-associating peptide, 18As [3]. 
Fourth, an attempt was made to position the Glu 
and Lys residues in order to take advantage of 
potential helix stabilization through the formation 
of salt bridges. Work on model peptides by Mar- 
qusee and Baldwin [9] indicate that salt bridges can 
form in a-helical peptides between Glu and Lys 
residues that reside at positions i and i+ 4. Salt 
bridges apparently do not form between such 
residues when they are located at positions i and 
i+ 3 in the peptide [9]. Extensive use of this form 
of stabilization was not compatible with the second 
and third considerations tated above. Most of the 
spacings between the Glu and Lys residues in the 
model peptide were i to i + 3 although one potential 
i to i + 4 salt bridge exists in the sequence. Finally, 
helix dipole stabilization [12] was considered and 
the peptides incorporate desamino N-termini and 
C-terminal amides to neutralize the detrimental 
terminal charges. In addition, an effort was made 
to arrange the distribution of Glu and Lys residues 
in the sequence such that the Glu residues,, were 
closer to the N-terminus and the Lys residues were 
closer to the C-terminus. Fig.1 shows the peptides 
that were synthesized. They are based on an eleven 
amino acid sequence, Glu-Leu-Leu-Glu-Lys-Leu- 
Leu-Glu-Lys-Leu-Lys, designated as MAP 
monomer or MAPi- 11, which was the product of 
the above criteria. 
2. EXPERIMENTAL SECTION 
Lys(Z-ClZ) and Trp(CH0). The N-terminal succinyl group was 
incorporated with the free W-amine peptide still attached to the 
resin using succinic anhydride in DMF/DCM (1: 1). Deprotec- 
tion and resin cleavage of the peptides was accomplished with 
HF/anisole/ethanedithiol(85 : 10: 5) at - 5°C (salt-ice bath) for 
40 min. Upon removal of the HF in vacua the peptides were 
precipitated with ether and extracted from the resin with 30% 
acetic acid. The extract was lyophilized and the residue purified 
by reverse-phase high-performance liquid chromatography 
(HPLC) using a Dynamax Cl8 column (40 x 250 mm) and 
acetonitrile in 0.1% aqueous trifluoroacetic acaid as an eluant. 
The purity and identity of the peptides was assessed by 
analytical HPLC, amino acid analysis and fast-atom bombard- 
ment mass spectrometry (table 1). 
2.2. Circular dichroic spectroscopy 
Circular dichroic spectra of peptide samples (1.7 x 10e4 and 
1.7 x 10e5 M in 0.1 M phosphate buffer, pH 7.4) in 1 mm 
cuvettes (Hellma) were obtained at 25°C on a Jasco J-5OOA 
spectra-polarimeter with a 2 nm slit width. The CD of buffer 
alone was subtracted from the CD of the sample after each 
scan. For purposes of the calculation of the molar ellipticities 
the N-terminal succinyl group was considered to be a residue. 
A total of nine scans were averaged (fig.3). By the method of 
Morrisett et al. [13] the molar ellipticities at 222 nm were used 
to obtain estimates of the secondary structure of the peptides in 
solution (table 2). 
3. RESULTS AND DISCUSSION 
Peptides l-6 (fig.1) were synthesized by solid- 
phase techniques. They represent different lengths 
and phases of the MAP sequence. The term 
‘phase’ refers to peptides beginning at different 
points in the repeating eleven amino acid sequence. 
The N-termini are succinylated and the C-termini 
are amides to remove the positively charged ter- 
minal groups. A Trp residue replaces one of the 
Lys residues in all but the shortest peptide. This 
residue was incorporated as a fluorescent reporter 
group. Table 1 gives the analytical information on 
the peptides. All of the peptides have good water 
solubility. Circular dichroic (CD) spectra were run 
on the peptides in 0.1 M phosphate buffer at 25°C 
(fig.3). These peptides exhibited the greatest 
amount of a-helical content yet reported for pep- 
tides of this length under these conditions. Com- 
pound 5, a seventeen amino acid peptide, gave a 
spectrum at 1.7 x 10m4 M that was in- 
distinguishable from the polylysine spectrum that 
is typically used as a standard for defining 100% cy- 
helical conformation (table 2). The tendency to 
form a-helix is very strong as demonstrated by the 
presence of a large amount of a-helical content 
(51% at 1.7 x 10e4 M) observed for the decapep- 
2.1. Peptide synthesis 
The peptides were synthesized by solid-phase methods on an 
Applied Biosystems model 430A peptide synthesizer using pro- 
tocols supplied by the manufacturer. The W-t-Boc-protected 
amino acids (Peptides Intl) were double coupled as their sym- 
metrical anhydrides, first with dimethylformamide (DMF), 
then with dichloromethane (DCM) as a solvent, to p- 
methylbenzhydrylamine r sin (0.65 mmol amine/g resin; Pep- 
tides Intl). The side chain protection used was Glu(Bal), 
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Fig.1. Amino acid sequences of MAP, analogs l-6, 18As (7; [3]), an 18As analog (8; [5]), a model apolipoprotein A-I peptide (9; 
[l]) and a model lipid associating peptide (LAP-20, 10; [7]). Regions homologous to the MAP sequence in the latter four peptides 
are indicated by underlining of the residues. MAP is the oligomer X-Yn-Z where X is a C-terminal fragment of the eleven amino acid 
.MAP monomer, Y is the MAP monomer epeated n times and Z is an N-terminal fragment of the MAP monomer. Numbering begins 
with the first MAP monomer fragment. Residues in the subsequent MAP repeats are designated with the sequential addition of a prime 
symbol to the MAP monomer residue number. Compound 1 is N”-succinyl-[Trp9’]-MAP s 11, amide. Compound 2 is W-succinyl- -
[Trp9’]MAPs-rr, amide. Compound 3 is W-succinyl-[TrpqMAPs-rr amide. Compound 4 is IV-succinyl-MAP5-rr amide. 
Compound 5 is W-succinyl-[T$‘]MAPs-3, I amide. Compound 6 is W-succinyl-[TrpslMAPs-s,. 
tide 3. The a-helical content observed was concen- tions also gives evidence of greater aggregation 
tration dependent, particularly in the cases of the with increasing concentration, but the formation 
decapeptides suggesting that aggregation of the of distinct 4-helix bundles was not observed (not 
peptides lends added stability to the helical confor- shown). Even at 1.7 x lo-’ M, 1,2 and 5 exhibited 
mation. Taking this into account, the helical con- 51, 45 and 80% a-helical contents, respectively. 
tent observed for 5 is much greater than that The dramatic helix-forming tendencies of the 
observed for even the 74 amino acid, model 4-helix MAP sequence demonstrates that the various 
bundle protein, ~4, of DeGrado ([@I222 = - 21000) elements in the design of these peptides are com- 
[ 191. Gel filtration of 5 and 6 at varying concentra- plementary to one another. 
Table 1 
Amino acid analysis and FAB-MS for l-6 
Amino acid analysisa 
GlX Leu LYS 
Calcd FAB-MSb 
molecular (M + H)+ 
mass 
1 4.12 (4) 8.03 (8) 4.85 (5) 2364 2364 
2 3.06 (3) 6.01 (6) 3.93 (4) 1881 1883 
3 1.97 (2) 5.09 (5) 1.94 (2) 1383 1384 
4 0.89 (1) 3.20 (3) 2.91 (3) 970 971 
5 4.09 (4) 7.85 (8) 4.06 (4) 2236 2236 
6 2.03 (2) 4.98 (5) 2.00 (2) 1383 1383 
* 6 N HCl: 24 h or 48 h at 106°C 
b (M+H)+ f 1 mU 
Within a series having the same phase of the 
MAP sequence, l-4, a-helical content decreased 
with the length of the peptide. When comparing 
peptides of comparable length but different phas- 
ing (e.g. 1 vs 5) the a-helical content was not 
predictable and was apparently due to either 
overall hydrophobicity (1 contains one more 
hydrophilic residue than 5) or to a yet un- 
parameterized form of stabilization (e.g. some 
measure of the ability of a peptide to self ag- 
gregate), since it did not correlate with the number 
of i to i+4 salt bridges, helix dipole stabilization, 
the per residue helical moment [14], the Chou- 
Fasman [l l] (P,) or the length of the peptide 
(table 2). Different phases of the sequence having 
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Table 2 
Physical data and calculations for 1 to 10 
Corn- Chou-Fasman’ Eisenbergb No. No. Overall 
pound 
Morrisett et al.c analysis of CD spectra (25°C) 
per residue amino i to charge 
no. (Pm> (Pi3> (Pt> moment acids i+4 pH 7 In 0.1 M phosphate With DMPC 80% TFE 
salt 1.7 x 1O-4 M 1.7 x 1O-5 M 1.7 x 10-s M 1.7 x lo-’ M 
bridges 
vl222+ lo3 %(Y [8]222 + 10” %cu L9l222+ 10’ %cr [&22 + 10s %(y 
1 1.26 0.94 0.80 0.442 @ 103” 18 1 0 -28.1 76 -19.8 51 -19.5 50 -19.8 51 
2 1.25 0.95 0.80 0.414 @ 104” 14 1 0 -25.7 69 -17.9 45 -20.8 54 -17.9 45 
3 1.25 1.01 0.74 0.422 @ 106” 10 1 - 1 -19.9 51 -5.6 8 -12.2 28 -7.4 13 
4 1.23 0.93 0.79 0.547 @ 117” 7 0 + 1 -3.0 0 -0.1 0 +13.4 d +17.2 d 
5 1.26 0.95 0.74 0.395 @ 101” 17 1 - 1 -36.7 100 -29.5 80 -38.3 100 -32.1 88 
6 1.25 1.01 0.74 0.419 Q 102” 10 0 - 1 -15.6 38 0.7 0 -18.7 48 -8.6 17 
7 1.08 0.91 0.97 0.264 @ 95” 24 1 0 - - -3.l’J 0 -8.6’ 17 -12.6 27 
8 1.21 1.01 0.76 0.352 @ 94” 18 1 0 - - -6.2’ 10 - - - - 
9 1.26 0.81 0.81 0.270 @ 99” 22 2 + 1 - 16.5h 41 -8.7h 17 - - - - 
10 1.02 0.97 1.02 0.276 @ 102” 20 0 0 - - -8’ 15 -31’ 85 - - 
; ;;:; 
’ [13] Vo o-helix = -(([&22 + 3000)/33000) x 100 
d Under these conditions the peptide exhibited a CD spectrum indicative of ,&tum conformation 
: 1:; in 0.02 M sodium phosphate, pH 7.4 
r [5] in 0.01 M sodium phosphate, pH 7.0, 150 mM NaCl, 25°C at 5.7 x lo-’ M 
h [l] in 0.01 M phosphate buffer, pH 7.0, at concentrations of 1.7 x 10m4 and 3 x 10e6 M 
i [7] 6.2 x lo-’ M at 12°C 
a similar length, as exemplified by compounds 3 
and 6, behaved similarly under the conditions that 
were examined, but 6 had greater a-helical content 
in the presence of lipid than 3 (48% vs 28%). Both 
have almost identical Chou-Fasman and helical 
moment parameters. Compound 3 has the poten- 
tial for a salt bridge between the N-terminal suc- 
cinyl group and Lys-5 and the Glu and Lys residues 
of this peptide are better distributed for helix 
dipole stabilization than they are in 6. The degree 
to which the various elements of helix stabilization 
affect lipid interaction, aggregation and helix- 
forming ability of peptides cannot be assessed us- 
ing these data. 
In the presence of lipid or 80% trifluoroethanol 
in 0.1 M phosphate buffer most of the peptides ex- 
hibited enhanced a-helical content relative to that 
seen in phosphate buffer alone. Compound 4, 
which contains only seven amino acids, exhibits no 
a-helical content alone or in the presence of lipid 
or 80% trifluoroethanol. It does appear to have a 
high degree of &turn content, based on com- 
parison to standard spectra [15], which is enhanced Fig.2. Edmundson wheel diagram [20] of 1. 
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Fig.3. Circular dichroism spectra of l-5. 
by the presence of lipid or 8Q% trifluoropthanol. 
This degree of structure for such a short linear pep- 
tide containing no unusually hindered amino acids 
is remarkable. No p-turns are indicated by Chou- 
Fasman calculations. The sequence Lys-Asp, but 
not Orn-Asp or Asp-Lys, has been reported to lead 
to the stabilization of &turn structures via side 
chain interaction [16]. Peptide 4 eontains a Glu- 
Lys sequence. We are not aware of any evidence , L 
that this sequence could also stabilize a &turn con- 
formation, but it is a possibility that cannot be dis- 
counted at this time. Therefore, the driving force 
for the transition from cu-helical to p-turn structure 
upon shortening of the peptide is unclear. The 
enhancement of strugture by lipid suggests the im- 
portance of amphipathic structure in the overall 
conformation. 
In conclusion, the understanding of the factors 
that influence the secondary structure of peptides 
has been greatly advanced in recent years by the 
study of model peptides [l-10,12]. Utilization of 
the elements leading to structural stability allows 
the enhancement of secondary structure in model 
peptides, as demonstrated in this paper. Thus, 
studies into the basic mechanisms of structural for- 
mation in peptides and proteins may soon prove to 
be most valuable in the design of synthetic proteins 
[ 18,191 and pharmaceutically useful materials. 
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